Acknowledgement
This study was supported by a research fund from Chosun University, 2020. The authors would like to specially thank Jeonju Pharmaceutical Association (JPA) for conducting the cooperation in this study.
References
- Herges JR, Borah BJ, Moriarty JP, Garrison GM, Gullerud RE, Angstman KB. Impact of collaborative clinician visits on postdischarge total cost of care in a polypharmacy population. Am J Health Syst Pharm 2020;77(22):1859-65. https://doi.org/10.1093/ajhp/zxaa192
- Sehgal V, Bajwa SJ, Sehgal R, Bajaj A, Khaira U, Kresse V. Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital. J Family Med Prim Care 2013;2(2):194-9. https://doi.org/10.4103/2249-4863.117423
- Picker D, Heard K, Bailey TC, Martin NR, LaRossa GN, Kollef MH. The number of discharge medications predicts thirty-day hospital readmission: a cohort study. BMC Health Serv Res 2015;15:282. https://doi.org/10.1186/s12913-015-0950-9
- Leffler ME, Elliott DP, Thompson S, Dean LS. Medication-related readmission risk assessment in older adult patients. J Am Coll Clin Pharm 2019;2(6):652-9. https://doi.org/10.1002/jac5.1104
- Fennelly JE, Coe AB, Kippes KA, Remington TL, Choe HM. Evaluation of clinical pharmacist services in a transitions of care program provided to patients at highest risk for readmission. J Pharm Pract 2020;33(3):314-20. https://doi.org/10.1177/0897190018806400
- El Morabet N, Uitvlugt EB, van den Bemt BJ, van den Bemt PM, Janssen MJ, Karapinar-Carkit F. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc 2018;66(3):602-8. https://doi.org/10.1111/jgs.15244
- Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360(14):1418-28. https://doi.org/10.1056/NEJMsa0803563
- Daliri S, Hugtenburg JG, Ter Riet G, et al. The effect of a pharmacy-led transitional care program on medication-related problems post-discharge: A before-after prospective study. PLoS One 2019;14(3):e0213593. https://doi.org/10.1371/journal.pone.0213593
- Bae-Shaaw YH, Eom H, Chun RF, Steven Fox D. Real-world evidence on impact of a pharmacist-led transitional care program on 30- and 90-day readmissions after acute care episodes. Am J Health Syst Pharm 2020;77(7):535-45. https://doi.org/10.1093/ajhp/zxaa012
- Layman SN, Elliott WV, Regen SM, Keough LA. Implementation of a pharmacist-led transitional care clinic. Am J Health Syst Pharm 2020;77(12):966-71. https://doi.org/10.1093/ajhp/zxaa080
- March KL, Peters MJ, Finch CK, et al. Pharmacist transition-of-care services improve patient satisfaction and decrease hospital readmissions. J Pharm Pract 2022;35(1):86-93. https://doi.org/10.1177/0897190020958264
- Snyder ME, Krekeler CE, Jaynes HA, et al. Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions. Am J Health Syst Pharm 2020;77(12):931-7. https://doi.org/10.1093/ajhp/zxaa091
- Miller D, Ramsey M, L'Hommedieu TR, Verbosky L. Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system. Am J Health Syst Pharm 2020;77(12):972-8. https://doi.org/10.1093/ajhp/zxaa071
- Melody KT, McCartney E, Sen S, Duenas G. Optimizing care transitions: the role of the community pharmacist. Integr Pharm Res Pract 2016;5:43-51. https://doi.org/10.4103/2279-042X.176559
- Ensing HT, Koster ES, van Berkel PI, van Dooren AA, Bouvy ML. Problems with continuity of care identified by community pharmacists post-discharge. J Clin Pharm Ther 2017;42(2):170-7. https://doi.org/10.1111/jcpt.12488
- Park HY, Sohn HS, Kwon JW. Reviews on the current status and appropriate management of polypharmacy in South Korea. Korean J Clin Pharm 2018;28(1):1-9. https://doi.org/10.24304/kjcp.2018.28.1.1
- Nam YS, Han JS, Kim JY, Bae WK, Lee K. Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study. BMC Geriatr 2016;16:118. https://doi.org/10.1186/s12877-016-0285-3
- Chang TI, Park H, Kim DW, et al. Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study. Sci Rep 2020;10(1):18964. https://doi.org/10.1038/s41598-020-75888-8
- Yang SY, Jang S, Kwon SH, et al. Effectiveness of the pilot project for polypharmacy management. Health and Social Welfare Review 2020;40(3):563-91. https://doi.org/10.15709/HSWR.2020.40.3.563
- Seo DS, Yoon JL, Kim SJ, Park JS, Lee WJ, Kim MY. Polypharmacy in older patients admitted to a general hospital. J Korean Geriatr Soc 2012;16(3):133-40. https://doi.org/10.4235/jkgs.2012.16.3.133
- Shin J, Han SH, Choi J, Kim YS, Lee J. The experience of providing older adult patients with transitional care from an acute care hospital to home in cooperation with a public health center. J Korean Med Sci 2020;35(39):e348. https://doi.org/10.3346/jkms.2020.35.e348
- Park S, Choi N, Seo Y, et al. The effects of medication reconciliation on drug use and cost-saving by multidisciplinary geriatric care team. J Korean Soc Health Syst Pharm 2019;36(4):432-41. https://doi.org/10.32429/jkshp.2019.36.4.001
- Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003;25(5):218-26. https://doi.org/10.1023/A:1025860402256
- George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother 2004;38(9):1369-76. https://doi.org/10.1345/aph.1D479
- Libby AM, Fish DN, Hosokawa PW, et al. Patient-level medication regimen complexity across populations with chronic disease. Clin Ther 2013;35(4):385-98.e1. https://doi.org/10.1016/j.clinthera.2013.02.019
- Kim SO. Medication adherence of elderly with hypertension and/or diabetes-mellitus and its' influencing factors. Korean J Clin Pharm 2011;21(2):81-9.
- Gruneir A, Dhalla IA, van Walraven C, et al. Unplanned readmissions after hospital discharge among patients identified as being at high risk for readmission using a validated predictive algorithm. Open Med 2011;5(2):e104-11.
- Choi HJ. The internal current status and prospect of reports of adverse drug reactions of herbal medicine: The necessity of report of adverse drug reactions of herbal medicine and henceforth task. J Pharmacoepidemiol Risk Manag 2018;10(1):1-8.
- Fugh-Berman A. Herb-drug interactions. Lancet 2000;355(9198):134-8. https://doi.org/10.1016/S0140-6736(99)06457-0
- Ministry of Food and Drug Safety. Korea Food and drug statistical yearbook. 2020. Available from https://www.mfds.go.kr/brd/m_371/view.do?seq=30719&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1. Accessed February 16, 2022.
- Park SJ, Kwon YK, Shin JG. Current status of herb-drug interaction information and information database in Korea. Journal of Physiology & Pathology in Korean Medicine 2010;24(4):543-52.
- Lee S, Jang JY, Yang S, et al. Development and validation of the Korean version of the medication regimen complexity index. PLoS One 2019;14(5):e0216805. https://doi.org/10.1371/journal.pone.0216805
- Hawes EM, Pinelli NR, Sanders KA, et al. Post-hospital discharge care: a retrospective cohort study exploring the value of pharmacist-enhanced care and describing medication-related problems. N C Med J 2018;79(1):4-13.
- Kelling SE, Bright DR, Ulbrich TR, Sullivan DL, Gartner J, Cornelius DC. Development and implementation of a community pharmacy medication therapy management-based transition of care program in the managed Medicaid population. Inov Pharm 2013;4(4):137.
- Monte SV, Passafiume SN, Kufel WD, et al. Pharmacist home visits: A 1-year experience from a community pharmacy. J Am Pharm Assoc 2016;56(1):67-72. https://doi.org/10.1016/j.japh.2015.11.002